

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.08561253 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.84513912 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.80275547 |
| 4 | behavioral response to nicotine (GO:0035095) | 5.28652509 |
| 5 | locomotory exploration behavior (GO:0035641) | 5.20463848 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.14037568 |
| 7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.07713898 |
| 8 | vocalization behavior (GO:0071625) | 4.79153730 |
| 9 | glutamate secretion (GO:0014047) | 4.77307790 |
| 10 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.58952022 |
| 11 | neurotransmitter secretion (GO:0007269) | 4.54194618 |
| 12 | regulation of synaptic vesicle transport (GO:1902803) | 4.52737176 |
| 13 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.34645485 |
| 14 | neuron cell-cell adhesion (GO:0007158) | 4.31667685 |
| 15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.28502379 |
| 16 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.25879496 |
| 17 | neuronal action potential propagation (GO:0019227) | 4.21917551 |
| 18 | exploration behavior (GO:0035640) | 4.11319972 |
| 19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.09476900 |
| 20 | neuromuscular process controlling posture (GO:0050884) | 4.04482230 |
| 21 | proline transport (GO:0015824) | 4.01865583 |
| 22 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.95705302 |
| 23 | protein localization to synapse (GO:0035418) | 3.94336353 |
| 24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.92833003 |
| 25 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.91542645 |
| 26 | gamma-aminobutyric acid transport (GO:0015812) | 3.89364259 |
| 27 | cellular potassium ion homeostasis (GO:0030007) | 3.88510776 |
| 28 | presynaptic membrane assembly (GO:0097105) | 3.84630579 |
| 29 | activation of protein kinase A activity (GO:0034199) | 3.84516225 |
| 30 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.81566589 |
| 31 | neurotransmitter transport (GO:0006836) | 3.79783723 |
| 32 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.75713022 |
| 33 | layer formation in cerebral cortex (GO:0021819) | 3.69199866 |
| 34 | auditory behavior (GO:0031223) | 3.66177417 |
| 35 | synaptic transmission, glutamatergic (GO:0035249) | 3.65664593 |
| 36 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.64382333 |
| 37 | cerebellar Purkinje cell layer development (GO:0021680) | 3.62898282 |
| 38 | presynaptic membrane organization (GO:0097090) | 3.59083022 |
| 39 | sodium ion export (GO:0071436) | 3.57262118 |
| 40 | glutamate receptor signaling pathway (GO:0007215) | 3.53938688 |
| 41 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.50709994 |
| 42 | neuronal action potential (GO:0019228) | 3.50011868 |
| 43 | neuron-neuron synaptic transmission (GO:0007270) | 3.49412787 |
| 44 | long-term memory (GO:0007616) | 3.46587925 |
| 45 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.46113757 |
| 46 | regulation of neurotransmitter levels (GO:0001505) | 3.45420386 |
| 47 | regulation of synapse structural plasticity (GO:0051823) | 3.42927488 |
| 48 | cell communication by electrical coupling (GO:0010644) | 3.42880542 |
| 49 | nucleobase catabolic process (GO:0046113) | 3.41178873 |
| 50 | glycine transport (GO:0015816) | 3.40460693 |
| 51 | dendritic spine morphogenesis (GO:0060997) | 3.39699150 |
| 52 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.37354257 |
| 53 | regulation of vesicle fusion (GO:0031338) | 3.37128026 |
| 54 | positive regulation of membrane potential (GO:0045838) | 3.28759885 |
| 55 | serotonin metabolic process (GO:0042428) | 3.28218121 |
| 56 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.28013252 |
| 57 | neuron recognition (GO:0008038) | 3.27667578 |
| 58 | synaptic vesicle endocytosis (GO:0048488) | 3.27006808 |
| 59 | vesicle transport along microtubule (GO:0047496) | 3.25579372 |
| 60 | L-fucose catabolic process (GO:0042355) | 3.25437445 |
| 61 | fucose catabolic process (GO:0019317) | 3.25437445 |
| 62 | L-fucose metabolic process (GO:0042354) | 3.25437445 |
| 63 | innervation (GO:0060384) | 3.24778788 |
| 64 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.23965152 |
| 65 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.23006647 |
| 66 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.21206510 |
| 67 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.17607611 |
| 68 | regulation of neurotransmitter secretion (GO:0046928) | 3.17466261 |
| 69 | primary amino compound metabolic process (GO:1901160) | 3.17344362 |
| 70 | transmission of nerve impulse (GO:0019226) | 3.17088639 |
| 71 | membrane depolarization during action potential (GO:0086010) | 3.16649162 |
| 72 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.14958029 |
| 73 | detection of calcium ion (GO:0005513) | 3.14698679 |
| 74 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.13855727 |
| 75 | behavioral response to ethanol (GO:0048149) | 3.12564014 |
| 76 | chemosensory behavior (GO:0007635) | 3.10975503 |
| 77 | mechanosensory behavior (GO:0007638) | 3.10369221 |
| 78 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.08791590 |
| 79 | regulation of postsynaptic membrane potential (GO:0060078) | 3.08747602 |
| 80 | insulin secretion (GO:0030073) | 3.08366866 |
| 81 | regulation of synaptic plasticity (GO:0048167) | 3.05182418 |
| 82 | response to pheromone (GO:0019236) | 3.02082124 |
| 83 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.01702788 |
| 84 | neuromuscular synaptic transmission (GO:0007274) | 2.99731995 |
| 85 | neuromuscular process controlling balance (GO:0050885) | 2.97319329 |
| 86 | mating behavior (GO:0007617) | 2.97287047 |
| 87 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.96560899 |
| 88 | signal release (GO:0023061) | 2.96347606 |
| 89 | regulation of ARF protein signal transduction (GO:0032012) | 2.96265814 |
| 90 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.96238613 |
| 91 | long-term synaptic potentiation (GO:0060291) | 2.94441469 |
| 92 | regulation of neurotransmitter transport (GO:0051588) | 2.94095852 |
| 93 | potassium ion import (GO:0010107) | 2.93908952 |
| 94 | potassium ion homeostasis (GO:0055075) | 2.93767963 |
| 95 | postsynaptic membrane organization (GO:0001941) | 2.93690889 |
| 96 | axon ensheathment in central nervous system (GO:0032291) | 2.93170138 |
| 97 | central nervous system myelination (GO:0022010) | 2.93170138 |
| 98 | axonal fasciculation (GO:0007413) | 2.93118926 |
| 99 | startle response (GO:0001964) | 2.91651629 |
| 100 | suckling behavior (GO:0001967) | 2.91080826 |
| 101 | regulation of exocytosis (GO:0017157) | 2.89931094 |
| 102 | regulation of respiratory system process (GO:0044065) | 2.89784544 |
| 103 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.89702162 |
| 104 | organelle transport along microtubule (GO:0072384) | 2.88865311 |
| 105 | axon cargo transport (GO:0008088) | 2.87767723 |
| 106 | dendrite morphogenesis (GO:0048813) | 2.87703691 |
| 107 | cell migration in hindbrain (GO:0021535) | 2.87430261 |
| 108 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.87394191 |
| 109 | positive regulation of exocytosis (GO:0045921) | 2.86709902 |
| 110 | neuronal ion channel clustering (GO:0045161) | 2.86698724 |
| 111 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.86570239 |
| 112 | positive regulation of synapse maturation (GO:0090129) | 2.86357891 |
| 113 | social behavior (GO:0035176) | 2.86250392 |
| 114 | intraspecies interaction between organisms (GO:0051703) | 2.86250392 |
| 115 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.86123093 |
| 116 | membrane hyperpolarization (GO:0060081) | 2.85044724 |
| 117 | response to auditory stimulus (GO:0010996) | 2.84025453 |
| 118 | synapse assembly (GO:0007416) | 2.84009215 |
| 119 | regulation of neurotransmitter uptake (GO:0051580) | 2.83733965 |
| 120 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.83308962 |
| 121 | regulation of action potential (GO:0098900) | 2.83244637 |
| 122 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.82376794 |
| 123 | synaptic transmission (GO:0007268) | 2.82356344 |
| 124 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.82109309 |
| 125 | membrane depolarization (GO:0051899) | 2.81613931 |
| 126 | synaptic vesicle transport (GO:0048489) | 2.80142650 |
| 127 | establishment of synaptic vesicle localization (GO:0097480) | 2.80142650 |
| 128 | urinary tract smooth muscle contraction (GO:0014848) | 2.78972971 |
| 129 | positive regulation of synapse assembly (GO:0051965) | 2.77299827 |
| 130 | action potential (GO:0001508) | 2.76288575 |
| 131 | C4-dicarboxylate transport (GO:0015740) | 2.75135291 |
| 132 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.71587293 |
| 133 | atrial cardiac muscle cell action potential (GO:0086014) | 2.70855413 |
| 134 | cAMP catabolic process (GO:0006198) | 2.66771312 |
| 135 | adult walking behavior (GO:0007628) | 2.66241429 |
| 136 | adult behavior (GO:0030534) | 2.65101135 |
| 137 | synaptic transmission, cholinergic (GO:0007271) | 2.61540167 |
| 138 | protein polyglutamylation (GO:0018095) | 2.61375261 |
| 139 | detection of light stimulus involved in visual perception (GO:0050908) | 2.60423337 |
| 140 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.60423337 |
| 141 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.60359205 |
| 142 | regulation of synapse maturation (GO:0090128) | 2.59506840 |
| 143 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.58751575 |
| 144 | protein localization to cilium (GO:0061512) | 2.57568841 |
| 145 | positive regulation of dendritic spine development (GO:0060999) | 2.56452175 |
| 146 | indole-containing compound metabolic process (GO:0042430) | 2.56317859 |
| 147 | behavioral defense response (GO:0002209) | 2.54599792 |
| 148 | behavioral fear response (GO:0001662) | 2.54599792 |
| 149 | potassium ion transmembrane transport (GO:0071805) | 2.52888415 |
| 150 | cellular potassium ion transport (GO:0071804) | 2.52888415 |
| 151 | indolalkylamine metabolic process (GO:0006586) | 2.50793132 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.04347238 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.35619111 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.01657244 |
| 4 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.97489308 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.93151947 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.81241250 |
| 7 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.57279062 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.54791407 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.52502167 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.50140029 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.50140029 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.48367014 |
| 13 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.45761181 |
| 14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.44463527 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.44346875 |
| 16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.44328617 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.41958611 |
| 18 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.41690367 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.37311616 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.34600559 |
| 21 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.21267201 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.20602719 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.19637219 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.13460846 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.03549956 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.99575749 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.99023020 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.88823146 |
| 29 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.79411076 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.76333360 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.76148978 |
| 32 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.70470615 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.69758270 |
| 34 | FUS_26573619_Chip-Seq_HEK293_Human | 1.60933479 |
| 35 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.54432882 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.51083085 |
| 37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.49915531 |
| 38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.47801885 |
| 39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.47344795 |
| 40 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46084321 |
| 41 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.46084321 |
| 42 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.44834448 |
| 43 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.44253744 |
| 44 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.42078903 |
| 45 | EWS_26573619_Chip-Seq_HEK293_Human | 1.41746491 |
| 46 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.41606709 |
| 47 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.38730743 |
| 48 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36661465 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36040642 |
| 50 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.35709333 |
| 51 | STAT3_23295773_ChIP-Seq_U87_Human | 1.31501323 |
| 52 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.29013808 |
| 53 | AR_19668381_ChIP-Seq_PC3_Human | 1.26377418 |
| 54 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25563431 |
| 55 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.25518515 |
| 56 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.24390062 |
| 57 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22541783 |
| 58 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.22475433 |
| 59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21553894 |
| 60 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21366642 |
| 61 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20298139 |
| 62 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.20078524 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.17751128 |
| 64 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.17540406 |
| 65 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16663468 |
| 66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16461254 |
| 67 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.14674891 |
| 68 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.13113055 |
| 69 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.13113055 |
| 70 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12709455 |
| 71 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.12292904 |
| 72 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11547587 |
| 73 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.10789167 |
| 74 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.09807883 |
| 75 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09073603 |
| 76 | TCF4_23295773_ChIP-Seq_U87_Human | 1.09042777 |
| 77 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.08883088 |
| 78 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08716562 |
| 79 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.08599249 |
| 80 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08232691 |
| 81 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.05999349 |
| 82 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.05621044 |
| 83 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.05415854 |
| 84 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03970673 |
| 85 | KDM2B_26808549_Chip-Seq_K562_Human | 1.03480580 |
| 86 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03148082 |
| 87 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.03065426 |
| 88 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.02996681 |
| 89 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02711682 |
| 90 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.01506192 |
| 91 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.01474270 |
| 92 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01045439 |
| 93 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01029785 |
| 94 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.00571467 |
| 95 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00421585 |
| 96 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99739132 |
| 97 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99227542 |
| 98 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98716506 |
| 99 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98329136 |
| 100 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98153722 |
| 101 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.98040980 |
| 102 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.98034207 |
| 103 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97433225 |
| 104 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.97111487 |
| 105 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.96322142 |
| 106 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.96322142 |
| 107 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.96110066 |
| 108 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95854862 |
| 109 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95397256 |
| 110 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95316093 |
| 111 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95233473 |
| 112 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94165581 |
| 113 | KDM2B_26808549_Chip-Seq_REH_Human | 0.93407581 |
| 114 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.92789336 |
| 115 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.92300821 |
| 116 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.91743109 |
| 117 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.91035508 |
| 118 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91028343 |
| 119 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.90395503 |
| 120 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88131511 |
| 121 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87790204 |
| 122 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87582423 |
| 123 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.86577007 |
| 124 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.86426027 |
| 125 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.86310265 |
| 126 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85615010 |
| 127 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.84459498 |
| 128 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.83078241 |
| 129 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.82281062 |
| 130 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.81750258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.43073832 |
| 2 | MP0003880_abnormal_central_pattern | 4.22022444 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.77562314 |
| 4 | MP0004270_analgesia | 3.46923421 |
| 5 | MP0009745_abnormal_behavioral_response | 3.02620422 |
| 6 | MP0002064_seizures | 2.91763687 |
| 7 | MP0002063_abnormal_learning/memory/cond | 2.88480735 |
| 8 | MP0009046_muscle_twitch | 2.86474701 |
| 9 | MP0002909_abnormal_adrenal_gland | 2.83776083 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.73971576 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.68288337 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.66772563 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.57138045 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.57039742 |
| 15 | MP0002272_abnormal_nervous_system | 2.47083781 |
| 16 | MP0003122_maternal_imprinting | 2.41192844 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.36475456 |
| 18 | MP0005645_abnormal_hypothalamus_physiol | 2.25813295 |
| 19 | MP0003283_abnormal_digestive_organ | 2.25279626 |
| 20 | MP0002733_abnormal_thermal_nociception | 2.16734881 |
| 21 | MP0001486_abnormal_startle_reflex | 2.11123243 |
| 22 | MP0006276_abnormal_autonomic_nervous | 2.10694755 |
| 23 | MP0002735_abnormal_chemical_nociception | 2.07658686 |
| 24 | MP0005646_abnormal_pituitary_gland | 2.02746972 |
| 25 | MP0008877_abnormal_DNA_methylation | 1.99902030 |
| 26 | MP0001970_abnormal_pain_threshold | 1.98084196 |
| 27 | MP0001440_abnormal_grooming_behavior | 1.92180505 |
| 28 | MP0002736_abnormal_nociception_after | 1.88813205 |
| 29 | MP0003787_abnormal_imprinting | 1.87579965 |
| 30 | MP0000013_abnormal_adipose_tissue | 1.86144540 |
| 31 | MP0004858_abnormal_nervous_system | 1.85059981 |
| 32 | MP0002067_abnormal_sensory_capabilities | 1.84178387 |
| 33 | MP0002822_catalepsy | 1.83412359 |
| 34 | MP0004147_increased_porphyrin_level | 1.77362507 |
| 35 | MP0002184_abnormal_innervation | 1.74749228 |
| 36 | MP0010386_abnormal_urinary_bladder | 1.74631974 |
| 37 | MP0008569_lethality_at_weaning | 1.73483707 |
| 38 | MP0003329_amyloid_beta_deposits | 1.71455734 |
| 39 | MP0004742_abnormal_vestibular_system | 1.69832400 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.68047221 |
| 41 | MP0003646_muscle_fatigue | 1.66806572 |
| 42 | MP0004811_abnormal_neuron_physiology | 1.64245000 |
| 43 | MP0004043_abnormal_pH_regulation | 1.58630992 |
| 44 | MP0005386_behavior/neurological_phenoty | 1.56877886 |
| 45 | MP0004924_abnormal_behavior | 1.56877886 |
| 46 | MP0000955_abnormal_spinal_cord | 1.56273806 |
| 47 | MP0003879_abnormal_hair_cell | 1.47893929 |
| 48 | MP0004133_heterotaxia | 1.45974747 |
| 49 | MP0001502_abnormal_circadian_rhythm | 1.43643214 |
| 50 | MP0000778_abnormal_nervous_system | 1.36210632 |
| 51 | MP0002837_dystrophic_cardiac_calcinosis | 1.35098806 |
| 52 | MP0001984_abnormal_olfaction | 1.34792845 |
| 53 | MP0002102_abnormal_ear_morphology | 1.33923366 |
| 54 | MP0002066_abnormal_motor_capabilities/c | 1.32802851 |
| 55 | MP0002882_abnormal_neuron_morphology | 1.30757037 |
| 56 | MP0008961_abnormal_basal_metabolism | 1.30711093 |
| 57 | MP0003195_calcinosis | 1.29001970 |
| 58 | MP0003633_abnormal_nervous_system | 1.28997306 |
| 59 | MP0001485_abnormal_pinna_reflex | 1.26915484 |
| 60 | MP0004885_abnormal_endolymph | 1.26306566 |
| 61 | MP0006292_abnormal_olfactory_placode | 1.24599951 |
| 62 | MP0004142_abnormal_muscle_tone | 1.22330177 |
| 63 | MP0002638_abnormal_pupillary_reflex | 1.21435984 |
| 64 | MP0004145_abnormal_muscle_electrophysio | 1.18928552 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 1.18890111 |
| 66 | MP0002693_abnormal_pancreas_physiology | 1.17367056 |
| 67 | MP0005253_abnormal_eye_physiology | 1.13915088 |
| 68 | MP0003183_abnormal_peptide_metabolism | 1.13912052 |
| 69 | MP0005379_endocrine/exocrine_gland_phen | 1.13830380 |
| 70 | MP0001529_abnormal_vocalization | 1.13413821 |
| 71 | MP0001905_abnormal_dopamine_level | 1.10185324 |
| 72 | MP0005535_abnormal_body_temperature | 1.09518136 |
| 73 | MP0003172_abnormal_lysosome_physiology | 1.07145804 |
| 74 | MP0001944_abnormal_pancreas_morphology | 1.06813065 |
| 75 | MP0002653_abnormal_ependyma_morphology | 1.06364263 |
| 76 | MP0008875_abnormal_xenobiotic_pharmacok | 1.06167604 |
| 77 | MP0002229_neurodegeneration | 1.06131513 |
| 78 | MP0006072_abnormal_retinal_apoptosis | 1.05033583 |
| 79 | MP0003136_yellow_coat_color | 1.04520256 |
| 80 | MP0003631_nervous_system_phenotype | 1.01057470 |
| 81 | MP0002069_abnormal_eating/drinking_beha | 0.99648890 |
| 82 | MP0000427_abnormal_hair_cycle | 0.97363727 |
| 83 | MP0003123_paternal_imprinting | 0.95519020 |
| 84 | MP0002152_abnormal_brain_morphology | 0.92830970 |
| 85 | MP0000631_abnormal_neuroendocrine_gland | 0.92788506 |
| 86 | MP0005174_abnormal_tail_pigmentation | 0.90793263 |
| 87 | MP0003634_abnormal_glial_cell | 0.89107699 |
| 88 | MP0002928_abnormal_bile_duct | 0.88482234 |
| 89 | MP0005551_abnormal_eye_electrophysiolog | 0.87747843 |
| 90 | MP0001188_hyperpigmentation | 0.87241645 |
| 91 | MP0003011_delayed_dark_adaptation | 0.86776498 |
| 92 | MP0002938_white_spotting | 0.85001978 |
| 93 | MP0002078_abnormal_glucose_homeostasis | 0.84985557 |
| 94 | MP0002877_abnormal_melanocyte_morpholog | 0.84699579 |
| 95 | MP0003137_abnormal_impulse_conducting | 0.84531339 |
| 96 | MP0000026_abnormal_inner_ear | 0.84390438 |
| 97 | MP0004085_abnormal_heartbeat | 0.83472575 |
| 98 | MP0005195_abnormal_posterior_eye | 0.82540349 |
| 99 | MP0002163_abnormal_gland_morphology | 0.82265290 |
| 100 | MP0003121_genomic_imprinting | 0.81244640 |
| 101 | MP0001299_abnormal_eye_distance/ | 0.79295782 |
| 102 | MP0008872_abnormal_physiological_respon | 0.76727537 |
| 103 | MP0000569_abnormal_digit_pigmentation | 0.76367620 |
| 104 | MP0000751_myopathy | 0.75932550 |
| 105 | MP0001986_abnormal_taste_sensitivity | 0.75421370 |
| 106 | MP0002876_abnormal_thyroid_physiology | 0.74835927 |
| 107 | MP0000003_abnormal_adipose_tissue | 0.73287504 |
| 108 | MP0002160_abnormal_reproductive_system | 0.72173651 |
| 109 | MP0003119_abnormal_digestive_system | 0.72161758 |
| 110 | MP0003953_abnormal_hormone_level | 0.71785864 |
| 111 | MP0003690_abnormal_glial_cell | 0.70763913 |
| 112 | MP0003632_abnormal_nervous_system | 0.69313788 |
| 113 | MP0005394_taste/olfaction_phenotype | 0.68271585 |
| 114 | MP0005499_abnormal_olfactory_system | 0.68271585 |
| 115 | MP0001664_abnormal_digestion | 0.68071848 |
| 116 | MP0002751_abnormal_autonomic_nervous | 0.67389838 |
| 117 | MP0001177_atelectasis | 0.66958496 |
| 118 | MP0002234_abnormal_pharynx_morphology | 0.66567062 |
| 119 | MP0004130_abnormal_muscle_cell | 0.66539963 |
| 120 | MP0000604_amyloidosis | 0.65331194 |
| 121 | MP0000566_synostosis | 0.65294805 |
| 122 | MP0000230_abnormal_systemic_arterial | 0.64711386 |
| 123 | MP0001963_abnormal_hearing_physiology | 0.64610807 |
| 124 | MP0008874_decreased_physiological_sensi | 0.64231317 |
| 125 | MP0001765_abnormal_ion_homeostasis | 0.63642607 |
| 126 | MP0002090_abnormal_vision | 0.63034172 |
| 127 | MP0004233_abnormal_muscle_weight | 0.62517936 |
| 128 | MP0000678_abnormal_parathyroid_gland | 0.62189928 |
| 129 | MP0002752_abnormal_somatic_nervous | 0.61458571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.39872923 |
| 2 | Visual hallucinations (HP:0002367) | 5.60083239 |
| 3 | Myokymia (HP:0002411) | 5.22735366 |
| 4 | Focal seizures (HP:0007359) | 4.98010211 |
| 5 | Atonic seizures (HP:0010819) | 4.37531873 |
| 6 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.32236382 |
| 7 | Absence seizures (HP:0002121) | 4.07543794 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.04528868 |
| 9 | Epileptic encephalopathy (HP:0200134) | 4.02387546 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 3.88791354 |
| 11 | Febrile seizures (HP:0002373) | 3.81113112 |
| 12 | Molar tooth sign on MRI (HP:0002419) | 3.73981292 |
| 13 | Abnormality of midbrain morphology (HP:0002418) | 3.73981292 |
| 14 | Generalized tonic-clonic seizures (HP:0002069) | 3.71972712 |
| 15 | Action tremor (HP:0002345) | 3.69482067 |
| 16 | Dialeptic seizures (HP:0011146) | 3.64188999 |
| 17 | Papilledema (HP:0001085) | 3.61903709 |
| 18 | Pancreatic cysts (HP:0001737) | 3.55705329 |
| 19 | Agitation (HP:0000713) | 3.51452332 |
| 20 | Depression (HP:0000716) | 3.41860484 |
| 21 | Pancreatic fibrosis (HP:0100732) | 3.41322977 |
| 22 | Pheochromocytoma (HP:0002666) | 3.40067464 |
| 23 | Congenital stationary night blindness (HP:0007642) | 3.38617759 |
| 24 | Ankle clonus (HP:0011448) | 3.28191243 |
| 25 | Nephronophthisis (HP:0000090) | 3.23985030 |
| 26 | Anxiety (HP:0000739) | 3.15265450 |
| 27 | True hermaphroditism (HP:0010459) | 3.13470634 |
| 28 | Truncal ataxia (HP:0002078) | 3.07231085 |
| 29 | Neuroendocrine neoplasm (HP:0100634) | 2.92485747 |
| 30 | Inability to walk (HP:0002540) | 2.88643258 |
| 31 | Postural instability (HP:0002172) | 2.87600044 |
| 32 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.87406268 |
| 33 | Lissencephaly (HP:0001339) | 2.86833468 |
| 34 | Epileptiform EEG discharges (HP:0011182) | 2.86382106 |
| 35 | Abnormality of the renal medulla (HP:0100957) | 2.83605321 |
| 36 | EEG with generalized epileptiform discharges (HP:0011198) | 2.83370803 |
| 37 | Abnormal eating behavior (HP:0100738) | 2.80866717 |
| 38 | Failure to thrive in infancy (HP:0001531) | 2.74423494 |
| 39 | Hypsarrhythmia (HP:0002521) | 2.71676349 |
| 40 | Protruding tongue (HP:0010808) | 2.68455271 |
| 41 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.68128717 |
| 42 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.66165474 |
| 43 | Poor eye contact (HP:0000817) | 2.66031020 |
| 44 | Impaired smooth pursuit (HP:0007772) | 2.63842471 |
| 45 | Ventricular fibrillation (HP:0001663) | 2.62965001 |
| 46 | Dysdiadochokinesis (HP:0002075) | 2.62880732 |
| 47 | Mutism (HP:0002300) | 2.62256580 |
| 48 | Genetic anticipation (HP:0003743) | 2.59705291 |
| 49 | Dysmetria (HP:0001310) | 2.59294905 |
| 50 | Medial flaring of the eyebrow (HP:0010747) | 2.58579055 |
| 51 | Gaze-evoked nystagmus (HP:0000640) | 2.56341432 |
| 52 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.54760067 |
| 53 | Gait imbalance (HP:0002141) | 2.54542440 |
| 54 | Neurofibrillary tangles (HP:0002185) | 2.53403967 |
| 55 | Retinal dysplasia (HP:0007973) | 2.52536109 |
| 56 | Impaired social interactions (HP:0000735) | 2.51794539 |
| 57 | Abnormal social behavior (HP:0012433) | 2.51794539 |
| 58 | Hemiparesis (HP:0001269) | 2.51767127 |
| 59 | Menstrual irregularities (HP:0000858) | 2.51438617 |
| 60 | Broad-based gait (HP:0002136) | 2.49531609 |
| 61 | Cerebral inclusion bodies (HP:0100314) | 2.45705369 |
| 62 | Limb dystonia (HP:0002451) | 2.44988455 |
| 63 | Abnormality of the renal cortex (HP:0011035) | 2.44843143 |
| 64 | Hypercortisolism (HP:0001578) | 2.44399510 |
| 65 | Amblyopia (HP:0000646) | 2.43080188 |
| 66 | Bradykinesia (HP:0002067) | 2.42750245 |
| 67 | Drooling (HP:0002307) | 2.41859745 |
| 68 | Excessive salivation (HP:0003781) | 2.41859745 |
| 69 | Cystic liver disease (HP:0006706) | 2.41833811 |
| 70 | Chronic hepatic failure (HP:0100626) | 2.39205698 |
| 71 | Hypoglycemic seizures (HP:0002173) | 2.38455962 |
| 72 | Pachygyria (HP:0001302) | 2.36402612 |
| 73 | Birth length less than 3rd percentile (HP:0003561) | 2.36316734 |
| 74 | Spastic gait (HP:0002064) | 2.35241187 |
| 75 | Progressive inability to walk (HP:0002505) | 2.34444066 |
| 76 | Hemiplegia (HP:0002301) | 2.31773283 |
| 77 | Abolished electroretinogram (ERG) (HP:0000550) | 2.31764589 |
| 78 | Diplopia (HP:0000651) | 2.27274460 |
| 79 | Abnormality of binocular vision (HP:0011514) | 2.27274460 |
| 80 | Abnormal drinking behavior (HP:0030082) | 2.26720762 |
| 81 | Polydipsia (HP:0001959) | 2.26720762 |
| 82 | Attenuation of retinal blood vessels (HP:0007843) | 2.24873071 |
| 83 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.24866006 |
| 84 | Pendular nystagmus (HP:0012043) | 2.23671370 |
| 85 | Decreased circulating renin level (HP:0003351) | 2.21474617 |
| 86 | Hyperventilation (HP:0002883) | 2.17360147 |
| 87 | Postural tremor (HP:0002174) | 2.16988818 |
| 88 | Abnormality of alanine metabolism (HP:0010916) | 2.16938664 |
| 89 | Hyperalaninemia (HP:0003348) | 2.16938664 |
| 90 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.16938664 |
| 91 | Intention tremor (HP:0002080) | 2.16534887 |
| 92 | Abnormality of the lower motor neuron (HP:0002366) | 2.16189701 |
| 93 | Psychosis (HP:0000709) | 2.13846286 |
| 94 | Tubular atrophy (HP:0000092) | 2.12896412 |
| 95 | Torticollis (HP:0000473) | 2.12593762 |
| 96 | Polyphagia (HP:0002591) | 2.11793456 |
| 97 | Insomnia (HP:0100785) | 2.11069551 |
| 98 | Symptomatic seizures (HP:0011145) | 2.09777383 |
| 99 | Urinary urgency (HP:0000012) | 2.08342906 |
| 100 | Scanning speech (HP:0002168) | 2.08310491 |
| 101 | Patellar aplasia (HP:0006443) | 2.07366296 |
| 102 | Chorioretinal atrophy (HP:0000533) | 2.05793345 |
| 103 | Hypothermia (HP:0002045) | 2.05601439 |
| 104 | Large for gestational age (HP:0001520) | 2.04921425 |
| 105 | Cerebellar dysplasia (HP:0007033) | 2.04523112 |
| 106 | Hypoventilation (HP:0002791) | 2.02406790 |
| 107 | Congenital primary aphakia (HP:0007707) | 2.01524392 |
| 108 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.00123285 |
| 109 | Increased circulating renin level (HP:0000848) | 1.99511592 |
| 110 | Lower limb muscle weakness (HP:0007340) | 1.98874972 |
| 111 | Sclerocornea (HP:0000647) | 1.98137976 |
| 112 | Neuronal loss in central nervous system (HP:0002529) | 1.96513177 |
| 113 | Focal dystonia (HP:0004373) | 1.96215299 |
| 114 | Severe muscular hypotonia (HP:0006829) | 1.95901123 |
| 115 | Clonus (HP:0002169) | 1.95822305 |
| 116 | Concave nail (HP:0001598) | 1.95793487 |
| 117 | Restlessness (HP:0000711) | 1.94595134 |
| 118 | Neoplasm of the heart (HP:0100544) | 1.94455814 |
| 119 | Macroorchidism (HP:0000053) | 1.92539271 |
| 120 | Decreased central vision (HP:0007663) | 1.92394078 |
| 121 | Status epilepticus (HP:0002133) | 1.92268470 |
| 122 | Megalencephaly (HP:0001355) | 1.92203608 |
| 123 | Termporal pattern (HP:0011008) | 1.91953402 |
| 124 | Insidious onset (HP:0003587) | 1.91953402 |
| 125 | Clumsiness (HP:0002312) | 1.91729923 |
| 126 | Keratoconus (HP:0000563) | 1.91217574 |
| 127 | Increased corneal curvature (HP:0100692) | 1.91217574 |
| 128 | Nephrogenic diabetes insipidus (HP:0009806) | 1.91155109 |
| 129 | Genital tract atresia (HP:0001827) | 1.90677898 |
| 130 | Optic nerve hypoplasia (HP:0000609) | 1.90271277 |
| 131 | Blue irides (HP:0000635) | 1.88945782 |
| 132 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.88499832 |
| 133 | Abnormal EKG (HP:0003115) | 1.87876150 |
| 134 | Gait ataxia (HP:0002066) | 1.87225670 |
| 135 | Abnormality of the corticospinal tract (HP:0002492) | 1.86403941 |
| 136 | Absent speech (HP:0001344) | 1.86350153 |
| 137 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.85822112 |
| 138 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.85583691 |
| 139 | Hyperparathyroidism (HP:0000843) | 1.85087138 |
| 140 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.84919192 |
| 141 | Rigidity (HP:0002063) | 1.83002341 |
| 142 | Generalized myoclonic seizures (HP:0002123) | 1.79923637 |
| 143 | Adrenal overactivity (HP:0002717) | 1.78072567 |
| 144 | Polyuria (HP:0000103) | 1.77168708 |
| 145 | Retinal atrophy (HP:0001105) | 1.76700794 |
| 146 | Widely spaced teeth (HP:0000687) | 1.76654519 |
| 147 | Abnormality of the pons (HP:0007361) | 1.76565451 |
| 148 | Craniofacial dystonia (HP:0012179) | 1.75974656 |
| 149 | Abnormality of the labia minora (HP:0012880) | 1.75218693 |
| 150 | Type II lissencephaly (HP:0007260) | 1.74730469 |
| 151 | Furrowed tongue (HP:0000221) | 1.74107840 |
| 152 | Bundle branch block (HP:0011710) | 1.73989799 |
| 153 | Specific learning disability (HP:0001328) | 1.73765817 |
| 154 | Hypoplasia of the pons (HP:0012110) | 1.73758124 |
| 155 | Rapidly progressive (HP:0003678) | 1.73118186 |
| 156 | Vaginal atresia (HP:0000148) | 1.72894349 |
| 157 | Anterior segment dysgenesis (HP:0007700) | 1.72320744 |
| 158 | Dyskinesia (HP:0100660) | 1.70337265 |
| 159 | Anencephaly (HP:0002323) | 1.69270269 |
| 160 | Akinesia (HP:0002304) | 1.69209673 |
| 161 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.66821262 |
| 162 | Intellectual disability, severe (HP:0010864) | 1.65404297 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 5.09821497 |
| 2 | MAP3K9 | 3.75374819 |
| 3 | MAP3K4 | 3.09741070 |
| 4 | MARK1 | 2.79967407 |
| 5 | MINK1 | 2.65102240 |
| 6 | BMPR1B | 2.61032175 |
| 7 | EPHA4 | 2.59432864 |
| 8 | NTRK1 | 2.58481411 |
| 9 | ADRBK2 | 2.51068090 |
| 10 | MAP2K7 | 2.45084430 |
| 11 | PRKD3 | 2.41556249 |
| 12 | MAP3K12 | 2.17766249 |
| 13 | PAK6 | 2.12083499 |
| 14 | ACVR1B | 2.10547792 |
| 15 | NTRK2 | 2.09395879 |
| 16 | MAP2K4 | 1.98447003 |
| 17 | KSR2 | 1.85272818 |
| 18 | MAP4K2 | 1.76958497 |
| 19 | CAMKK1 | 1.74495570 |
| 20 | UHMK1 | 1.73225427 |
| 21 | INSRR | 1.72378123 |
| 22 | DAPK2 | 1.71810070 |
| 23 | PNCK | 1.69281108 |
| 24 | MAP3K2 | 1.66582927 |
| 25 | GRK1 | 1.61948019 |
| 26 | GRK5 | 1.61653301 |
| 27 | CDK5 | 1.50458060 |
| 28 | CAMKK2 | 1.44026144 |
| 29 | ZAK | 1.35984345 |
| 30 | STK38 | 1.35815615 |
| 31 | RIPK4 | 1.33069035 |
| 32 | DYRK2 | 1.32471307 |
| 33 | CASK | 1.31020332 |
| 34 | TLK1 | 1.27647261 |
| 35 | ARAF | 1.26830605 |
| 36 | STK39 | 1.26168312 |
| 37 | PRKCG | 1.23200748 |
| 38 | PRKCH | 1.20629593 |
| 39 | TNIK | 1.17813048 |
| 40 | MAPK13 | 1.17470774 |
| 41 | MAP3K1 | 1.17170075 |
| 42 | WNK3 | 1.16935795 |
| 43 | SCYL2 | 1.14144869 |
| 44 | PLK2 | 1.11844445 |
| 45 | DAPK1 | 1.09096552 |
| 46 | PAK3 | 1.08503117 |
| 47 | RET | 1.06078501 |
| 48 | KSR1 | 1.05479946 |
| 49 | FES | 1.04497827 |
| 50 | CDC42BPA | 1.01152664 |
| 51 | FGFR2 | 1.00743929 |
| 52 | SGK494 | 0.99745711 |
| 53 | SGK223 | 0.99745711 |
| 54 | CAMK2A | 0.99480692 |
| 55 | HIPK2 | 0.96469707 |
| 56 | PHKG2 | 0.96398589 |
| 57 | PHKG1 | 0.96398589 |
| 58 | CDK19 | 0.91929570 |
| 59 | CAMK1D | 0.91309386 |
| 60 | WNK1 | 0.90076033 |
| 61 | MKNK2 | 0.89024489 |
| 62 | SIK2 | 0.88574560 |
| 63 | TAF1 | 0.87538628 |
| 64 | MAPK15 | 0.87208593 |
| 65 | CAMK1 | 0.87078635 |
| 66 | ALK | 0.86975595 |
| 67 | SGK2 | 0.85709078 |
| 68 | CAMK2B | 0.82823753 |
| 69 | NUAK1 | 0.80769101 |
| 70 | PKN1 | 0.80263459 |
| 71 | CAMK1G | 0.79162696 |
| 72 | MAPKAPK5 | 0.78699812 |
| 73 | STK11 | 0.78084837 |
| 74 | SGK3 | 0.76722175 |
| 75 | FER | 0.75453561 |
| 76 | LMTK2 | 0.74283452 |
| 77 | CDK14 | 0.74248055 |
| 78 | MAP3K13 | 0.73447361 |
| 79 | LATS2 | 0.73401367 |
| 80 | CDK18 | 0.73140796 |
| 81 | WNK4 | 0.72745913 |
| 82 | CSNK1G2 | 0.72635249 |
| 83 | CDK15 | 0.72314966 |
| 84 | TGFBR1 | 0.71929216 |
| 85 | TYRO3 | 0.71000309 |
| 86 | PRPF4B | 0.69334174 |
| 87 | PINK1 | 0.68956035 |
| 88 | AKT3 | 0.67904729 |
| 89 | CSNK1G3 | 0.67367337 |
| 90 | PASK | 0.66284484 |
| 91 | CAMK2D | 0.65967633 |
| 92 | MAP2K6 | 0.65903793 |
| 93 | DYRK1A | 0.64841779 |
| 94 | TNK2 | 0.64460322 |
| 95 | MARK2 | 0.64222686 |
| 96 | CAMK4 | 0.63192262 |
| 97 | SGK1 | 0.63141705 |
| 98 | TAOK1 | 0.62752067 |
| 99 | PRKCE | 0.62462856 |
| 100 | CDK11A | 0.60944269 |
| 101 | CSNK1G1 | 0.58846513 |
| 102 | CSNK1A1L | 0.56878953 |
| 103 | RPS6KA3 | 0.54158126 |
| 104 | TAOK3 | 0.53306321 |
| 105 | RPS6KA2 | 0.52961879 |
| 106 | PDGFRA | 0.52587460 |
| 107 | MAPK10 | 0.52430482 |
| 108 | BRSK1 | 0.52152250 |
| 109 | CAMK2G | 0.50772373 |
| 110 | PRKACA | 0.48272761 |
| 111 | PDK1 | 0.48198170 |
| 112 | PDPK1 | 0.47292654 |
| 113 | BMPR2 | 0.47151038 |
| 114 | PTK2B | 0.45730482 |
| 115 | BCR | 0.43971136 |
| 116 | CSNK1A1 | 0.43510394 |
| 117 | NEK6 | 0.42663392 |
| 118 | RIPK1 | 0.42545096 |
| 119 | TXK | 0.42313670 |
| 120 | PRKG1 | 0.42008835 |
| 121 | PTK2 | 0.41555604 |
| 122 | PRKAA1 | 0.41264671 |
| 123 | BRAF | 0.40984458 |
| 124 | TIE1 | 0.40532273 |
| 125 | OXSR1 | 0.39755437 |
| 126 | PRKCZ | 0.39506174 |
| 127 | PRKCA | 0.37584114 |
| 128 | MAPK12 | 0.37352197 |
| 129 | FYN | 0.37273384 |
| 130 | PIK3CA | 0.37226082 |
| 131 | PRKCI | 0.37030872 |
| 132 | PRKCQ | 0.36331014 |
| 133 | PRKCB | 0.35672283 |
| 134 | ADRBK1 | 0.35578900 |
| 135 | FRK | 0.35516098 |
| 136 | TRIM28 | 0.34166740 |
| 137 | MAPKAPK3 | 0.32358101 |
| 138 | CSNK1D | 0.32139250 |
| 139 | NME1 | 0.31732463 |
| 140 | ERBB2 | 0.31638477 |
| 141 | CSNK1E | 0.31547225 |
| 142 | RPS6KA5 | 0.30773740 |
| 143 | LIMK1 | 0.27630021 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.45049102 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.42777962 |
| 3 | Insulin secretion_Homo sapiens_hsa04911 | 2.76955606 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.76248976 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.51863938 |
| 6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.50562050 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.46186769 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.42642299 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.41268617 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.29123429 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.26849663 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 2.21665252 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.10982828 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 2.00935815 |
| 15 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.95577724 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.94697892 |
| 17 | Cocaine addiction_Homo sapiens_hsa05030 | 1.93663188 |
| 18 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.87604778 |
| 19 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.83736358 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.81681402 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.81022254 |
| 22 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.79552277 |
| 23 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.76212425 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.72313311 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.71689531 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.66454024 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.54954621 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.53998859 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.53418708 |
| 30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.50410006 |
| 31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.46340043 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.42412543 |
| 33 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.36035322 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.34952263 |
| 35 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.34270932 |
| 36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.33965210 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.32646583 |
| 38 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.32276438 |
| 39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.28079317 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.27620745 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.26057479 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.23687522 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.21344488 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.21034087 |
| 45 | Gap junction_Homo sapiens_hsa04540 | 1.19354809 |
| 46 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.17892463 |
| 47 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.15361145 |
| 48 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.12319081 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.10883255 |
| 50 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.09622686 |
| 51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08863054 |
| 52 | Parkinsons disease_Homo sapiens_hsa05012 | 1.07886931 |
| 53 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.07681256 |
| 54 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.01655055 |
| 55 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.00939775 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.96657615 |
| 57 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.96162829 |
| 58 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93536992 |
| 59 | Melanogenesis_Homo sapiens_hsa04916 | 0.92791474 |
| 60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.92589631 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91505219 |
| 62 | Glioma_Homo sapiens_hsa05214 | 0.88668174 |
| 63 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88627719 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88620855 |
| 65 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.88361337 |
| 66 | Histidine metabolism_Homo sapiens_hsa00340 | 0.84952755 |
| 67 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.81766626 |
| 68 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.80665880 |
| 69 | Basal transcription factors_Homo sapiens_hsa03022 | 0.80277367 |
| 70 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79178117 |
| 71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.77191675 |
| 72 | Axon guidance_Homo sapiens_hsa04360 | 0.73118085 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72123287 |
| 74 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.67835522 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67412870 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66847962 |
| 77 | Huntingtons disease_Homo sapiens_hsa05016 | 0.64016099 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63361344 |
| 79 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61155356 |
| 80 | Circadian rhythm_Homo sapiens_hsa04710 | 0.60713955 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.59852134 |
| 82 | Phototransduction_Homo sapiens_hsa04744 | 0.59094125 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58867048 |
| 84 | Mineral absorption_Homo sapiens_hsa04978 | 0.58441096 |
| 85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58203148 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57921855 |
| 87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57224739 |
| 88 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56432677 |
| 89 | Alcoholism_Homo sapiens_hsa05034 | 0.56346490 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56157502 |
| 91 | Bile secretion_Homo sapiens_hsa04976 | 0.55164663 |
| 92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53979567 |
| 93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53071680 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52586536 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51993949 |
| 96 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51990359 |
| 97 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.51861064 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51598500 |
| 99 | Protein export_Homo sapiens_hsa03060 | 0.50353669 |
| 100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49732633 |
| 101 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49343742 |
| 102 | RNA polymerase_Homo sapiens_hsa03020 | 0.48544738 |
| 103 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.44528956 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.44364698 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44170382 |
| 106 | Peroxisome_Homo sapiens_hsa04146 | 0.44070617 |
| 107 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.44010142 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43823053 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42264321 |
| 110 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.42148232 |
| 111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.42115523 |
| 112 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41474944 |
| 113 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40484880 |
| 114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.39716040 |
| 115 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38571074 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38250160 |
| 117 | Alzheimers disease_Homo sapiens_hsa05010 | 0.38203527 |
| 118 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.37711886 |
| 119 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.36426331 |
| 120 | Lysosome_Homo sapiens_hsa04142 | 0.36346649 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35990367 |
| 122 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35903302 |
| 123 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.35857060 |
| 124 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34893868 |
| 125 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33817280 |
| 126 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.33677944 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33157980 |
| 128 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.31960877 |
| 129 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31647349 |
| 130 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.31231136 |
| 131 | Endometrial cancer_Homo sapiens_hsa05213 | 0.31195604 |
| 132 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31167856 |
| 133 | Retinol metabolism_Homo sapiens_hsa00830 | 0.30833218 |
| 134 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30349815 |
| 135 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.29779640 |
| 136 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29519195 |
| 137 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28360348 |
| 138 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.27025814 |

